<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 45 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page44.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=45">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 45 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 45</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=45"><img src="../thumb/45.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>14 / 2020-04                                                        Central Nervous System - 1.4.4
   part of pres. sympts., withdr.sympts.with abrupt discont., mania   LFT, incr.sweat., skin reacts.incl. photosens., alopec., angioed., ana-  Side effects: Incr.seiz.risk, alter.glycaem.contr., cutan.bleed.abnorm.,
   hist., concom.neurolept./meds. incr.bleed. risk, known tenden.to   phylact.reacts., arthralg./ myalg., urin.retent., sex.dysfunct., galact-  discont.sympt., seroton. syndr., dos.depend. QT interv.prolong., ventr.
   bleed/ predispos. condits./concom.oral anticoags., concom. alcoh.  orrh., fatig., cutan.bleed.abnormalit.incl. ecchymos.  dysrhythm.incl.torsade de point., seiz.thresh. lower., bld.dyscras., angi-
   not advis., Li ther., reduc. procyclidine dos.in case of anticholinerg.  Warnings and special precautions: Discont.if manic phase enter.,   oed., anaphylact./skin reacts., appet./mass chang., hyponatraem., hy-
   effs., hostility/suicide ideat.& self harm report.in childr., elderly, sev.  mania/hypoman.hist., paradox. anx.at start of panic disord.treatm.,   poglycaem., inappropr.ADH secret., psych./ micturit. disords., decr.libido,
   ren./hepat.impairm., discont. in cases of ser.liv.funct.abnormalit.,   discont. if seiz.developm./seiz.freq.incr., avoid in unstab. epilept.,   bruxism, CNS/psych. effs., dizzin., fatig., headache, trem., convuls., NMS,
   admin.in ser. CV disords.not studied., epilep., little clinic. exper. with   monit.contr.epilep., diabet.mellit., caref. monit.for poss.suic.esp.  dyskines.movem.disord., vis./GI disturbs., mydrias., tinnit., card.effs.incl.
   ECT, narrow angle glauc.     init., concom.meds. known to alt.platel. funct., bleed.hist disord., ECT,   prolong.ECG QT interv., orthostat.hypotens., sinusit., yawn., nas. congest.,
   Drug interactions: Toxic of risperidone poss. incr, poss.incr.bioavail.  serotonin syndr.risk with other serotonerg.meds.& antidepress. with   epistax., GI haemorrh., abnorm. LFT, hepatit., incr.sweat., alopec., ec-
   with cimetidine, decr. bioaval. with phenytoin, hepat.cytochrome P450   serotonerg.propert., concom.Li/ tryptophan/ cimetidine/desipramine,   chymos., asthen., arthralg., myalg., incr.bone fract.risk, urin.retent., sex.
   isozyme CYP2D6 respons.for metabol.of debrisoquine & sparteine is   monit INR with concom. warfar., elderly, hepat.insuff., withdr. grad.,   dysfunct.,  metrorrhag., menorrhag., galactorrh., priapism, pyrex., oed.
   inhibited enhanc. plasma lev.of concom.meds.metabol.by this isoen-  dos.-depend. QT interv.prolongat., pre-exist.QT interv. prolongat./card.  Warnings and special precautions: Elderly, hepat. impairm., seiz./
   zyme., poss.seroton.syndr.with tryptophan, incr. incid.of adverse effs.  dis., signif. bradycard., rec.ac.MI, uncompens. HF, electrol. disturbs.   hist.therof, uncontr.epilep., discont.if seiz.devel./manic phase enter/
   with anti-convuls., incr. procyclidine plasma lev.& other anti-cholin-  to be correct. bef.init.ther., cons.ECG bef. init.ther.in stable card.dis.,   seroton. syndr.sympt.developm./card.dysrhythm.signs, concom. ECT,
   ergs, poss. incr.bleed.in pres.of unalter.prothrob.times with warfar.  discont.ther.if dysrhythm. signs occur, bleed.disord.hist.  mania/hypoman.hist., pre-exist.slow heart rate, ac./recent MI, un-
   DEPRAMIL, Cipla Medpro [P/S]  Drug interactions: Enhanc.seroton.assoc.effs. with other sero-  compens.HF, diab. mellit., monit.pts.esp.dur.early ther.& dos.chang.
                                                              for clinic.worsen./suic.ideat./behav., monit.other psych. & non-psych.
                                tonerg.meds.& antidepress.with serotonerg. propert., enhanc.effs.
   Citalopram hydrobromide.     with Li & tryptophan, incr.AUC & Cmax with cimetidine, imipramine   disord.pts., cons.chang. ther./ discont.ther.if psych.sympt.occur which
   Indications: Depress.& prev.of relapse, panic disord.with/without   & desipramine plasma lev.incr., AUC of metoprol.& selegiline incr.,   are sev./ abrupt in onset/not part of pres.sympt., withdr. grad., hos-
   agoraphob., obsessive-compulsive disord.  incr.prothromb.time aft.warfar.  tilit./suic.ideat./self-harm in childr.with maj.depress.disord., paradox.
   (S5) TABS, A38/1.2/0489, 0490                              anx.init.dur.panic disord.treatm., akathis./psychomot.restlessn. dur. 1   st
   704328-001: 20 mg, 30, R97,26  DYNA SERTRALINE, Pharma Dynamics [P/S]  treatm.wks., hyponatraem.risk fact., concom. meds. with serotonerg.
   705252-001: 40 mg, 30, R145,13  Sertraline HCl.            effs., signif.bradycard., correct electr.disturbs.bef.init.ther., ECG advis.
   Dosage: Onset of act.2-4 wks. Contin.treatm.up to 6 mnths.aft.  Indications: Maj.depress.disords.such as sngl. episod. & recurr.  bef. init.ther.in stab.card.dis., angl.-clos.glauc./hist. thereof, avoid al-
   recov.to prev.relapse.       depress., obsess.compuls.disord., panic disord.with/-out agoraphob.  coh., concom.Li/tryptophan/meds. low. seiz.thresh./meds.metab.by
   Depress: Adults: 20 mg as sngl.dly.dos. Depend. on respons.may   (S5) TABS, 43/1.2/0339, 0340  CYP2C19 & have narr. therap.index/ some CNS act.meds.main. me-
   be incr.by 20 mg/day at 1 wk. interv. to max.60 mg.  719972-001: 50 mg, 30, R86,37  tab. by CYP2D6, excret.in breast milk, no exper. in sev. reduc.ren.funct.
   Panic disord: Init.10 mg dly.x1 wk.then incr.to 20 mg dly. Dos.may   719973-001: 100 mg, 30, R92,14  Drug interactions: Ser./potent.fatal reacts. resembl. seroton.syndr.
   be incr.further to max.60 mg dly.as reqd.  Dosage: Admin as sngl.dly.dos.  poss.with MAOI’s, incr. adverse effs.with St John’s Wort, incr.alcoh.
   Obsessive-compuls.disord: 20 mg/day as sngl. dos. Depend.  Depress: Init. 50 mg dly. Usual therapeut.dos. 50 mg dly. May be titr.  effs., incr. seroton.syndr.risk with other serotonerg. meds./ meds.
   on respons.dos.may be incr.by 20 mg increm.to max.60 mg/day.  up in 50 mg increm.at 2 wk. interv.to max.150-200 mg/day.  with serotonerg.activ., AUC/ max. plasma conc.incr.with cimetidine,
   Contraindications: MAOI, sev.ren.impairm., safety & effic.in pregn.   OCD: Eff.observ.within 1 wk.& full activ.aft.2-4 wks. Min.effect.dos.   meds.prolong QT interv.contra-indicat., incr.anticoag.activ.with war-
   & lactat.not est., safety & effic. in childr. und.18 yrs.not est.  50 mg dly. Incr.above 100 mg dly have no addit.benef.  far., incr.bleed.tend.with NSAIDs, incr.malign. dysrhythm.risk with
   Side effects: Decr.pulse rate, weight changes, CNS effs., convuls.,   Panic disord: Init.25 mg dly.incr.to 50 mg dly.aft. 1 wk. Min.  hypokalaem./ hypomagnesaem. induc.meds., enhanc.effs.with Li &
   serotonin syndr., neurolept. malign. syndr., suicid.ideat., self harm in   recomm.effect.dos: 50 mg dly. This regim. reduc.freq.of early treatm.  tryptophan, incr.desimipramine/metoprolol plasma lev., incr.plasma
   childr., accommodat.disturbs., mydrias., palpitat., trem., bradycard.,   emergent.S/E.  lev.with omeprazole.
   nas.congest., GI disturbs., hepatit., sweat., rash, asthen., micturit.  Contraindications: MAOI, childr.und.18 yrs., concom.pimozide,
   disords., sex. dysfunct.     safety in pregn.& lactat.not est.  ESCITALOPRAM WINTHROP, (Sanofi-Aventis) Winthrop [P/S]
   Special precautions: Elderly, hepat./ren. impairm., epilep./seiz.  Side effects: Freq: Headache, dzzin., trem., insomn., somnol., weight   Escitalopram
   hist., concom. electroconvuls. treatm., mania/hist.therof, discont. if   loss, thirst, diarrh., N&V, dspeps., anorex., flatul., male & fem.sex.dys-  Indications: Maj.depress.episod.
   pt.enters manic phase, pre-exist.slow heart rate, diab.mellit., monit.  funct., nervousn., rash, urticar., prurit., incr.sweat. Less freq: Palpitat.,   (S5) TABS, 43/1.2/0477, 0478, 0479
   pts.esp.dur.early ther.for suicid. ideat./behav., monit.other psych.&   paraesthes., hypoaesthes., twitch., hyperton., seiz., hyponatraem., hy-  720724-001: 5 mg, 30, R95,17
   non psych. disord. pts., withdr.grad., excret.in breast milk, serotonin   poglycaem., hyperprolactinaem., galactorrh., dry mouth, incr. appetit.,   720725-001: 10 mg, 30, R109,82
   syndr.more likely aft.dos.incr.  constipat., abdom.pain, menstr.sympt., micturit.freq.& disords.,agitat.,   720726-001: 20 mg, 30, R146,43
   Drug interactions: Incr.conc.of imipramine’s act. metabol.desimi-  anx., yawn., imp. concentrat., pschos., aggress., man/hypoman., ar-  Dosage: Adults: 10 mg as sngl.dly dos. Poss. incr.to max. 20 mg dly.
   pramine , incr.risk of serotonin syndr. with other serotonerg.meds/  thralg., myalg., vis.disturbs., tinnit., taste pervers., rhinit., pharyngit.,   depend.on indiv. respons. 2-4 wks.necess.for antidepress.respons.
   meds with serotonerg. activ., serotonin syndr.report.with moclobe-  anaphylact.reacts., ser. sickn., angoed., fatig., hot flushes, fev., back   Contraindications: Safety & effic.in childr.und. 18 yrs.not est.,
   mide overdos., effs.of alcoh.potent., anticoag. activ.of warfar.incr.,   pain. Freq.unknown: Atrial arrhythm., AV block, bradycard., QT pro-  MAOI’s, known QT prolong./ congenit. long QT syndr., meds.known
   AUC & max.plasma conc.incr.with cimetidine.  longat., ventric.tachycard., agranulocytos., aplast.anaem., incr.coag-  to prolong QT interv., safety in pregn.& lactat.not est., no info avail.
   DEPROZAN, Meridian Pharma div.of Elttab Pharmaceut. [P/S]  ulat.times, leucopen., pancytopen., thrombocytopen., extrapyramid.   on sev.ren.funct. impairm.
                                                              Side effects: Paradox.anx.at start of panic disord. treatm., glycaem.
                                sympts., NMS-like events, hypothyroid., hepatotox., jaund., liv.fail.,
   Fluoxetine HCl               pancreatit., hepatit., hepatomegaly, ac.ren.fail., opt. neurit., pulm.hy-  contr.alter., cutan.bleed.abnorm., seroton.syndr.risk, hyponatraem.,
   Indications: Maj.depress., bulim.nervosa, obsess. compuls.disords.  pertens., lupus-like syndr., Stev.-John.syndr., vasculit.  akathis., QT interv. prolongat., ventr.dysrhythm. incl.torsade de
   (S5) CAPS. .33/1.2/0541      Special precautions: Use for more than 12 wks. not eval.in panic   pointes, incr.sweat., thrombocytopen., anaphylact. reacts.incl.angi-
   894303-007: 20 mg, 30, R27,46  disord., re-eval.pt.in long term use, poss.activat.of mania/hypoman.,   oed., inappropr.ADH secret., appet. / weight chang., psych.disords.
   Dosage: Indiv.dosage.        poss. signific. weight loss, avoid in unstable epilep, monit.control.epi-  incl.suic.ideat./ suicid. behav., decr.libido, bruxism, dizzin., paraes-
   Depress: 20 mg/day. Dos.above 80 mg/day not recomm.  lept., discont.if seiz.develop, close supervis.of poss.suicide pts., uric   thes., trem., CNS effs., ocul.movem., myoclon., movem./reproduct.
   Bulimia: 60 mg/day recomm.   acid ser. lev. decr., risks/benefits of concom.ECT ther.not est., dis./con-  syst.disords., dyskines., seiz., mydrias., abnorm.vis., tinnit., fev.,
   Obsess.compuls.disords: 20-60 mg/day.  dits.affect.metabol./haemodynam. respons., not eval./used with MI/  bradycard., tachycard., postur.hypotens., sinusit., yawn., epistax., GI
   Contraindications: Sev.ren.fail., concom. MAOI/within 14 days   unstab.heart dis., ren./liv.impairm., worsen.depress./emerg. suicide   disturbs incl.rect.bleed., hepatit., skin reacts., hair loss, ecchymos.,
   of an MAOI/admin of an MAOI within 5 wks of discont.fluoxetine,   ideat./-behav risk in maj.depress./other psych./ non-psych.disords.,   arthralg., myalg., urin.retent., menorrhag., metrorrhag., galactorrh.,
   safety in pregn./ childr.& lactat.not est.  monit.pts.esp.dur early ther.& dos changes for clinic.worsen./suicid.  fatig., pyrex., oed., abnorm. LFT, poss.low.seiz.thresh.
   Side effects: Asthen., fev., palpitat., vis.disturbs., GI disords., CNS   ideat./ behav., consid.chang.therapeut.regim/discont.if psych.sympts.  Special precautions: Discont.if manic phase enter./seiz.developm./
   effs., dyspn., pulm.events, skin & anaphalactoid reacts., sex.dysfunct.,   occur which are sev./abrupt in onset/not part of pres.sympts., taper   incr.in seiz.freq./card. dysrhythm.signs, mania/hypoman.hist., contr. epi-
   hypothyroid., hyponatraem. Report.by no causal relationship est:   dos.dur. discont., switch.from other antidepress./anti-obsession.esp.  lep. but avoid in unstab.epilept., diab.mellit., concom.meds.known to aff.
   aplast. anaem., CVA, confus., dyskines., ecchymos., eosinophil.pne-  long act.agents, avoid concom.St John’s Wort, monit.prothromb.time,   platel.funct./ clopidogrel, bleed.disord.hist., concom.ECT, elderly &gt; 65 yrs.,
   um., GI haemorrh., hyperprolactinaem., movem.disords., neurolept.   monit.concom Li lev.as high.incid.of 5HT assoc.S/E, monit. concom.   hepat.insuff., grad.dos.reduct., hyponatream. risk, worsen.depress./
   malign.syndr.-like events, pancreatit., suic. ideation, bld.dyscras., vag.  sumatriptan, poss.alt.gluc.control theref. bld.gluc.monit.for diabet.,   emerg.suicid. ideat./-behav.risk in maj.depress./psych.disords., monit.
   bleed.aft.withdr., mania precipitat. if give for depress.in bipol.disord.  poss.incr.bleed.risk with concom.oral anticoags./salicylic acid de-  pts.esp.dur.early ther.& dos.chang.for clinic. worsen./suicid.ideat./behav.,
   Special precautions: Elderly, epilep., discont.if seiz./rash develop.,   rivat/ NSAID’s/atypic.antipsychot./phenothiaz.& most TCA’s., poss.  monit.other psych.& non psych. disord., consid.chang.therapeut.regim/
   ren./liv.impairm., ac.card.dis., underweight pts., diabet., poss adjustm   hyponatraem.& SIADH predisposit.in elderly on diuret., adeq.contra-  discont.if psych.sympts.occur which are sev./ abrupt in onset/not part of
   to insul. &/oral hypoglycaem.dos.  cept.in women of child bear.potent.,extrapyramid.disords., hostility/   pres.sympts., signif. bradycard., rec.ac.MI, uncompens. HF, ECG bef. init.
   Drug interactions: Excess.sedat.with other CNS depress., &gt;2-fold   suicid. ideat. & self harm report.in childr.  ther.in case of stab.card.dis., electrol.imbal. correct.bef. init. ther., reduc.
   incr.in prev.stable plasma lev.of other antidepress., incr.& decr.Li   Interactions: Pimozide plasma lev.incr.with poss.incr.dysrhythm.&   liv.funct., withdr. reacts. with sudd.withdr.aft.prolong.admin., concom. high
   lev., serotonerg. effs.enhanc.with tryptophan, half-life of diazepam   QT-interv.prolongat.risk, alcoh.not advis., agents enhanc. seroton-  dos. cimetidine, concom.Li/tryptoph./ warfar./other meds.low.seiz.thresh.
   poss. prolong., alt.plasma conc.of other plasma prot.bound drugs.  erg. neurotransmiss. eg.tryptophan & fenfluramine not advis., poss.  Drug interactions: Enhanc.seroton.assoc.effs. with other sero-
   DOLIN, Aurobindo [P/S]       serotonerg.potentiat.with St John’s Wort, signific.chang.in some   tonerg.meds.& antidepress. with serotonerg.propert., enhanc.effs.
   Escitalopram                 pharmacokinet. paramet.with diazepam & tolbutamide, cimetidine   with Li & tryptophan, incr. AUC & Cmax with cimetidine, imipramine
   Indications: Maj.depress.episodes.  decr.clear., incr. prothrombin time with warfar,   & desipramine plasma lev.incr., AUC of metoprol. & selegiline incr.,
   (S5) TABS, 44/1.2/0952, 0953  ESCITALOPRAM UNICORN, Unicorn [P/S]  incr.prothromb.time aft. warfar., incr.adverse eff.with St John’s Wort.
   720377-001: 10 mg, 30, R59,97  Escitalopram oxalate        FLUOXETINE ACTOR 20, (Actor Pharma) Cipla Medpro [P/S]
   720378-001: 20 mg, 30, R80,97  Indications: Maj.depress.episod., panic disord. with/without   Fluoxetine HCl equiv.to fluoxetine.
   Dosage: Maj.depress.episod: Adults: 10 mg as sngl.dly dos. May   agoraphob.  Indications: Maj.depress.episod., obsess. compuls. disord., bu-
   be incr.to max.20 mg dly. depend. on indiv. respons. 2-4 wks.necess.  (S5) TABS, 46/1.2/0341, 0343  lim.nervosa.
   for antidepress.respons.     722145-001: 10 mg, 28, R85,59  (S5) CAPS. 34/1.2/0094
   Contraindications: Safety & effic.in childr.und. 18 yrs.not est.,   722147-001: 20 mg, 28, R116,96  716520-001: 20 mg, 30, R34,34
   known QT interv. prolongat./ congen.long QT syndr./meds.known to   Dosage: Maj.depress.episod: Adults: 10 mg as sngl.dly dos. Poss.  Dosage: Maj.depress: 20 mg dly as sngl.morn. dos. Dos.up to
   prolong QT interv., MAOI’s, safety in pregn.& lactat.not est., no info   incr.to max.20 mg dly.depend.on indiv. respons. 2-4 wks.necess.for   80 mg may be giv.if need. Dos.to be div.with one in morn.& one at
   avail.on sev.ren.funct.impairm.  antidepress. respons.     noon if more than 20 mg requir.
   Side effects: Withdr.reacts.with abrupt discont., inapppropr.ADH   Panic disord.with/without agoraphob: 5 mg as sngl.dos.dly. for   Obsess.-compuls.disord: 20-60 mg dly.
   secret., GI disturbs., hyponatraem., weight loss, hyperprolactinaem.,   1  wk bef.incr.to 10 mg dly. May be furth.incr.as reqd.to max.20 mg   Bulimia: 60 mg dly.
                                 st
   decr. libido, suic.ideat., psych.disords., CNS effs., dizzin., sleep/  dly depend.on indiv.respons. Act.onset with.2-4 wks. Contin. treatm.   Elderly: Max.60 mg recomm. Skip miss.dos.& contin. on sched.with
   movem.disords., seiz., trem., serotonin syndr., ECG QT prolongat.,   for up to 6 mnths.aft.recov.to prevent relaps.  next dos.should dos.be miss.
   ventric. prolongat. & dysrhythm.incl.torsade de point. predomin. in   Contraindications: Known QT interv.prolong./ congenit. long QT   Contraindications: Sev.ren.fail., ac.MI phase, unstab. epilep., safety
   fem.with hypokalaem./pre-exist.QT interv. prolongat/other card.dis.,   syndr., meds.known to prolong QT interv.eg pimozide, MAOI’s, safety   in pregn.not est., lactat., safety & effic.in childr.not est., not suitab.
   abnorm.vis., postur. hypotens., sinusit., yawn., taste disturbs., abnorm.   & effic. in pregn.& lactat./childr.und.18 yrs.not est.  for bipol.illn., admin.of an MAOI within 5 wks of discont. fluoxetine.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page44.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page40.html">40</a>&nbsp;&nbsp;&nbsp;<a href="page41.html">41</a>&nbsp;&nbsp;&nbsp;<a href="page42.html">42</a>&nbsp;&nbsp;&nbsp;<a href="page43.html">43</a>&nbsp;&nbsp;&nbsp;<a href="page44.html">44</a>&nbsp;&nbsp;&nbsp;<a href="page45.html">45</a>&nbsp;&nbsp;&nbsp;<a href="page46.html">46</a>&nbsp;&nbsp;&nbsp;<a href="page47.html">47</a>&nbsp;&nbsp;&nbsp;<a href="page48.html">48</a>&nbsp;&nbsp;&nbsp;<a href="page49.html">49</a>&nbsp;&nbsp;&nbsp;<a href="page50.html">50</a>
             </td>
             <td width="35%"><a href="page46.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page46.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
